Consensus Canopy Growth Corporation

Equities

WEED

CA1380357048

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 14:11:18 2024-12-09 EST			5-day change	1st Jan Change
5.170 ^CAD	+0.98%		-3.00%	-23.52%

04:43pm	Canopy Growth Completes Acquisition of Acreage Holdings	MT
01:33pm	Canopy Growth Brief: Canopy Growth and Acreage Confirming Canopy USA's Completed Acquisition of Acreage	MT

Evolution of the Average Target: Canopy Growth Corporation

average-target-price-chart CANOPY-GROWTH-CORPORATION

Evolution of the Target Price: Canopy Growth Corporation

target-price-consensus-chart CANOPY-GROWTH-CORPORATION

Changes in Analyst Recommendations: Canopy Growth Corporation

38bb9cd2f1eee3355b8aaa92150af173.nzCWb-OBNCdzfN75en8s1_J_vQF1xkX2D0_3bp5mdb0.5gDHWbztYEYkCKSuDhdEvJ0VyFY0hy2ASyCoCsRWL-z0aPEorNdccj9Llw~d6c5a7ffac062a1983089d371e0c6e49

Analysts' recommendations: Canopy Growth Corporation

Piper Sandler Adjusts Price Target on Canopy Growth to $2 From $3, Maintains Underweight Rating	07-09	MT
Canopy Growth Slides After Constellation Directors Leave, Share Conversion	04-18	DJ
Canopy Growth Price Target Raised to $0.50 at CIBC	23-10-31	MT
Piper Sandler Cuts Canopy Growth Price Target to US$1, Reiterates Underweight	23-05-02	MT
Piper Sandler Trims Canopy Growth Price Target to $1 From $2, Maintains Underweight Rating	23-05-02	MT
Canopy Growth Target Price Lowered to $1.75 at CIBC	23-02-10	MT
Cantor Fitzgerald Adjusts Price Target on Canopy Growth to $3.30 From $3.05, Maintains Neutral Rating	22-11-07	MT
Bernstein Starts Canopy Growth at Underperform With $1.50 Price Target	22-11-02	MT
Cantor Fitzgerald Adjusts Canopy Growth's Price Target to $3.05 From $2.90, Keeps Neutral Rating	22-10-26	MT
Barclays Adjusts Canopy Growth's Price Target to $2 from $3.50, Maintains Underweight Rating	22-09-30	MT
Piper Sandler Trims Canopy Growth Target to US$2.50, Expects Canadian Retail Stores to be Divested	22-08-08	MT
Cantor Fitzgerald Lowers Canopy Growth's Price Target to CA$3.75 From CA$6.75, Maintains Neutral Rating	22-07-06	MT
Canaccord Genuity Adjusts Canopy Growth Price Target to CA$3.50 From CA$4.50, Maintains Sell Rating	22-07-01	MT
Canopy Growth Declines 20%, CIBC Lowers Price Target	22-06-30	MT
Piper Sandler Adjusts Canopy Growth's Price Target to $3 From $4, Reiterates Underweight Rating	22-06-30	MT
Jefferies Adjusts Canopy Growth's Price Target to CA$5.50 from CA$8.90, Keeps Hold Rating	22-06-13	MT
Barclays Adjusts Canopy Growth's Price Target to $3.50 From $6, Reiterates Underweight Rating	22-06-08	MT
BMO Capital Downgrades Canopy Growth to Underperform From Market Perform	22-06-08	MT
Piper Sandler Adjusts Canopy Growth's Price Target to $4 from $6, Keeps Underweight Rating	22-05-31	MT
Piper Sandler Lowers Canopy Growth Estimates on Softer Momentum, Cuts Target to US$6	22-04-01	MT
Analyst recommendations: Anaplan, Canopy Growth, FMC, Nike Philip Morris...	22-03-22
Barclays Downgrades Canopy Growth to Underweight From Equalweight	22-03-22	MT
Barclays Adjusts Canopy Growth's Price Target to $9 from $14, Maintains Equalweight Rating	22-03-01	MT
Cantor Fitzgerald Adjusts Canopy Growth's Price Target to CA$11 from CA$9.60, Maintains Neutral Rating	22-02-18	MT
Eight Capital Lowers Price Target for Canopy Growth to CA$7 From CA$12, Maintains Sell Rating	22-02-08	MT

More recommendations

Sector Comparison:

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
CANOPY GROWTH CORPORATION			+27.93%
DONG-E-E-JIAO CO.,LTD.			+32.06%
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.			+23.07%
TASLY PHARMACEUTICAL GROUP CO., LTD			+19.29%
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-	-	-
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-	-	-5.44%
HENAN LINGRUI PHARMACEUTICAL CO., LTD.			+35.06%
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	-	-	+36.42%
Average			+24.05%
Weighted average by Cap.			+24.69%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

5.120CAD

Average target price

6.550CAD

Spread / Average Target

+27.93%

High Price Target

15.00CAD

Spread / Highest target

+192.97%

Low Price Target

-CAD

Spread / Lowest Target

-100.00%

Analyst Consensus Detail

consensus-detail-chart CANOPY-GROWTH-CORPORATION

Consensus revision (last 18 months)

consensus-revision-chart CANOPY-GROWTH-CORPORATION

Analysts covering the company

CIBC World Markets
Piper Sandler
Cantor Fitzgerald
Bernstein
Barclays
Canaccord Genuity
Jefferies & Co.
BMO Capital
Eight Capital
MKM Partners
Alliance Global Partners
BofA Securities
Wells Fargo Securities
Cowen
Stifel Nicolaus
Desjardins
Benchmark Capital